iPrime Canaloplasty and iStent Infinite

Show Description +

Billy Pan, MD, presents the case of a patient who had cataract surgery with iStent placement back in 2015. Given uncontrolled IOP despite maximum medical therapy, we decided to pursue a combination of an iPrime Canaloplasty (Glaukos) and the additional placement of iStents via the newly FDA approved Infinite system (Glaukos).

Posted: 3/29/2023

Keywords:

iStent

iPrime Canaloplasty and iStent Infinite

Billy Pan, MD, presents the case of a patient who had cataract surgery with iStent placement back in 2015. Given uncontrolled IOP despite maximum medical therapy, we decided to pursue a combination of an iPrime Canaloplasty (Glaukos) and the additional placement of iStents via the newly FDA approved Infinite system (Glaukos).

Posted: 3/29/2023

Keywords:

iStent

Please log in to leave a comment.

More in Glaucoma

Implementing Interventional Glaucoma Treatment Protocols

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Treatment Patterns and Patient Compliance

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; and Deborah Ristvedt, DO

Practice Assessment Results

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

The Unmet Need for a Consensus Treatment Approach to Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD